Insider · CIK 0001424383

Germano Geno J

Reports to the SEC for 10 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001424383

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-25	DTILPRECISION BIOSCIENCES INCP Purchase	Director	PPurchase	+2,609 sh	$6.28	+$16.4K	47,492
2026-08-07	ENTXEntera Bio Ltd. · Stock Option (right to buy)A Award	Director	AAward	+43K sh	—	—	43,014
2026-08-07	ENTXEntera Bio Ltd. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2026-08-07	ENTXEntera Bio Ltd.A Award	Director	AAward	+25K sh	—	—	65,014
2026-06-03	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+21K sh	—	—	20,979
2026-05-20	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−21K sh	—	—	0
2026-05-20	DTILPRECISION BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+21K sh	—	—	44,883
2026-05-14	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionA Award	Director	AAward	+21.2K sh	—	—	21,231
2026-03-09	ENTXEntera Bio Ltd.P Purchase	Director	PPurchase	+20K sh	$1.30	+$26K	40,000
2026-02-10	ENTXEntera Bio Ltd.P Purchase	Director	PPurchase	+20K sh	$1.49	+$29.8K	—
2025-12-16	DTILPRECISION BIOSCIENCES INCP Purchase	Director	PPurchase	+3,000 sh	$4.72	+$14.2K	23,883
2025-07-31	Sage Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.5K sh	—	—	0
2025-06-11	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+21.5K sh	—	—	21,500
2025-06-03	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+21K sh	—	—	21,000
2025-05-27	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,826 sh	—	—	0
2025-05-27	DTILPRECISION BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+9,826 sh	—	—	20,883
2025-03-25	DTILPRECISION BIOSCIENCES INCP Purchase	Director	PPurchase	+3,250 sh	$5.30	+$17.2K	11,057
2024-12-30	DTILPRECISION BIOSCIENCES INCP Purchase	Director	PPurchase	+3,605 sh	$4.49	+$16.2K	7,807
2024-06-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-06-04	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+9,826 sh	—	—	9,826
2024-05-04	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,202 sh	—	—	0
2024-05-04	DTILPRECISION BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+4,202 sh	—	—	4,202
2023-06-15	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-05-04	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsA Award	Director	AAward	+126K sh	—	—	126,075
2022-06-16	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+9,947 sh	—	—	9,947
2022-05-10	DTILPRECISION BIOSCIENCES INC · Stock Option (Right to Buy)A Award	Director	AAward	+157K sh	—	—	156,951
2021-06-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-05-10	DTILPRECISION BIOSCIENCES INC · Stock Option (Right to Buy)A Award	Director	AAward	+32.8K sh	—	—	32,800
2020-06-09	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-03-10	DTILPRECISION BIOSCIENCES INC · Stock Option (Right To Buy)A Award	Director	AAward	+71.8K sh	—	—	71,776
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−8,410 sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−9,141 sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−27.2K sh	—	—	0
2020-01-06	MEDICINES CO /DED Disposition to Issuer	Director	DDisposition to Issuer	−7,429 sh	—	—	0
2019-06-05	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-05-30	MEDICINES CO /DEStock Options (right-to-buy)A Award	Director	AAward	+8,410 sh	—	—	8,410
2019-05-30	MEDICINES CO /DEA Award	Director	AAward	+3,663 sh	—	—	7,429
2019-01-03	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+878 sh	—	—	878
2018-06-06	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-05-31	MEDICINES CO /DEStock Option (right-to-buy)A Award	Director	AAward	+9,141 sh	—	—	9,141
2018-05-31	MEDICINES CO /DEA Award	Director	AAward	+3,766 sh	—	—	3,766
2018-03-08	Bioverativ Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,455 sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−21.7K sh	—	—	0
2018-01-31	Bioverativ Inc.Restricted Stock UnitsA Award	Director	AAward	+5,455 sh	—	—	5,455
2017-11-09	MEDICINES CO /DECall Option (right-to-buy)A Award	Director	AAward	+27.2K sh	—	—	27,243
2017-06-07	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2017-05-11	Bioverativ Inc.Non-Qualified Stock OptionA Award	Director	AAward	+21.7K sh	—	—	21,729
2016-09-22	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	President	AAward	+1M sh	—	—	1,000,000
2016-07-15	Sage Therapeutics, Inc.Stock Options (Right to buy)A Award	Director	AAward	+20.9K sh	$42.22	+$882K	20,883
2016-06-01	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	President	AAward	+2M sh	—	—	2,000,000

Recent filings

Accepted (ET)
Sep 294
Germano Geno J0001628280-26-063766
SEC(opens sec.gov)
Aug 74
Germano Geno J0001178913-26-003949
SEC(opens sec.gov)
Jun 54
Germano Geno J0001628280-26-041041
SEC(opens sec.gov)
May 224
Germano Geno J0001628280-26-037533
SEC(opens sec.gov)
May 184
Germano Geno J0001424383-26-000003
SEC(opens sec.gov)
Mar 114
Germano Geno J0001178913-26-000825
SEC(opens sec.gov)
Feb 114
Germano Geno J0001178913-26-000413
SEC(opens sec.gov)
Dec 174
Germano Geno J0001628280-25-057485
SEC(opens sec.gov)
Jul 314
Germano Geno J0000950170-25-100663
SEC(opens sec.gov)
Jun 134
Germano Geno J0001562180-25-004794
SEC(opens sec.gov)
Jun 44
Germano Geno J0000950170-25-081728
SEC(opens sec.gov)
Mar 274
Germano Geno J0000950170-25-045720
SEC(opens sec.gov)
Jan 24
Germano Geno J0000950170-25-000071
SEC(opens sec.gov)
Jun 114
Germano Geno J0001562180-24-004951
SEC(opens sec.gov)
Jun 64
Germano Geno J0000950170-24-069938
SEC(opens sec.gov)

Companies

Address

C/O PRECISION BIOSCIENCES, INC. 302 E. PETTIGREW ST., SUITE A-100

DURHAM, NC, 27701